Cas no 1238837-50-7 (gentiside J)
gentiside J Chemical and Physical Properties
Names and Identifiers
-
- gentiside J
- 1238837-50-7
- CHEMBL1254431
- docosyl 2,3-dihydroxybenzoate
- AKOS040761778
- CS-0159113
- NZB83750
-
- Inchi: 1S/C29H50O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-25-33-29(32)26-23-22-24-27(30)28(26)31/h22-24,30-31H,2-21,25H2,1H3
- InChI Key: ZYHQORYZNVHDNT-UHFFFAOYSA-N
- SMILES: O(C(C1C=CC=C(C=1O)O)=O)CCCCCCCCCCCCCCCCCCCCCC
Computed Properties
- Exact Mass: 462.37091007g/mol
- Monoisotopic Mass: 462.37091007g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 33
- Rotatable Bond Count: 23
- Complexity: 439
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 14
- Topological Polar Surface Area: 66.8?2
Experimental Properties
- Color/Form: Powder
- Density: 1.0±0.1 g/cm3
- Boiling Point: 562.7±30.0 °C at 760 mmHg
- Flash Point: 170.3±18.1 °C
- Vapor Pressure: 0.0±1.6 mmHg at 25°C
gentiside J Security Information
- Hazard Statement: H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
- Warning Statement: P264+P280+P305+P351+P338+P337+P313
- Safety Instruction: H303+H313+H333
- Storage Condition:Store at 4 ℃, better at -4 ℃
gentiside J Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | TN4127-1 mg |
Gentiside J |
1238837-50-7 | 1mg |
¥2435.00 | 2022-04-26 | ||
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | G18130-5 mg |
gentiside J |
1238837-50-7 | 5mg |
¥4800.0 | 2021-09-09 | ||
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | G18130-5mg |
gentiside J |
1238837-50-7 | ,97.0% | 5mg |
¥4800.0 | 2023-09-07 | |
| TargetMol Chemicals | TN4127-5mg |
Gentiside J |
1238837-50-7 | 5mg |
¥ 3330 | 2024-07-20 | ||
| TargetMol Chemicals | TN4127-5 mg |
Gentiside J |
1238837-50-7 | 98% | 5mg |
¥ 3,330 | 2023-07-11 | |
| TargetMol Chemicals | TN4127-1 mL * 10 mM (in DMSO) |
Gentiside J |
1238837-50-7 | 98% | 1 mL * 10 mM (in DMSO) |
¥ 3430 | 2023-09-15 | |
| TargetMol Chemicals | TN4127-1 ml * 10 mm |
Gentiside J |
1238837-50-7 | 1 ml * 10 mm |
¥ 3430 | 2024-07-20 |
gentiside J Related Literature
-
Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
-
Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
-
Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
-
Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
-
Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
Additional information on gentiside J
Comprehensive Overview of Gentiside J (CAS No. 1238837-50-7): Properties, Applications, and Research Insights
Gentiside J (CAS No. 1238837-50-7) is a bioactive compound garnering significant attention in pharmaceutical and nutraceutical research due to its unique structural properties and potential therapeutic benefits. As a derivative of gentiopicrin, this compound belongs to the class of iridoid glycosides, which are widely studied for their anti-inflammatory, antioxidant, and neuroprotective effects. Researchers and industry professionals are increasingly exploring Gentiside J for its role in addressing modern health challenges, such as oxidative stress-related disorders and metabolic syndromes.
The molecular structure of Gentiside J features a glucose moiety linked to a secoiridoid aglycone, which enhances its bioavailability and bioactivity. This structural characteristic makes it a promising candidate for drug development, particularly in the fields of natural product chemistry and precision medicine. Recent studies have highlighted its potential in modulating cellular pathways associated with inflammation and aging, aligning with the growing consumer interest in longevity science and holistic wellness.
In the context of current research trends, Gentiside J is often compared to other well-known iridoids like aucubin and catalpol, due to shared mechanisms of action. However, its distinct pharmacokinetic profile sets it apart, making it a subject of specialized investigations. For instance, its ability to cross the blood-brain barrier has sparked interest in applications for neurodegenerative diseases, a hot topic in biomedical research and AI-driven drug discovery platforms.
From an industrial perspective, the extraction and synthesis of Gentiside J are optimized for scalability, leveraging advanced techniques such as high-performance liquid chromatography (HPLC) and enzymatic bioconversion. These methods ensure high purity and yield, meeting the stringent demands of pharmaceutical-grade compounds. Furthermore, its compatibility with green chemistry principles aligns with the global push toward sustainable production practices, a key concern for environmentally conscious stakeholders.
Consumer interest in Gentiside J is also driven by its presence in traditional herbal formulations, particularly in East Asian medicine. This historical use, combined with modern validation, positions it as a bridge between ancient remedies and evidence-based therapeutics. Frequently searched questions include: "How does Gentiside J support cognitive health?" and "What are the synergistic effects of Gentiside J with other nootropics?"—reflecting the public's focus on mental performance enhancement.
In summary, Gentiside J (CAS No. 1238837-50-7) represents a multifaceted compound with expansive applications in health and biotechnology. Its integration into nutraceutical formulations, cosmeceuticals, and targeted therapies underscores its versatility. As research continues to unravel its mechanisms, this compound is poised to play a pivotal role in addressing contemporary health priorities, from metabolic resilience to cellular repair.
1238837-50-7 (gentiside J) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)